New Drug Approvals

Home » New drugs EU » Launch of Ipsen/Braintree’s Eziclen/Izinova in Europe expected by end 2013

Launch of Ipsen/Braintree’s Eziclen/Izinova in Europe expected by end 2013

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

ORGANIC SPECTROSCOPY

Read all about Organic Spectroscopy on ORGANIC SPECTROSCOPY INTERNATIONAL 

Categories

Recent Posts

Blog Stats

  • 4,043,793 hits

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,752 other followers

add to any

Share

Eziclen® / Izinova® a new bowel cleansing preparation, is a sulphate-based formulation (sodium, magnesium and potassium sulphates).

The dose for cleansing the colon will require two administrations of about 0.5 litre / 16 ounces of the product diluted in water, each followed by about 1 litre / 32 ounces, of clear liquids, each.

The drug will be registered under the trade name Eziclen® in the large majority of the concerned EU countries and under the name Izinova® in the other few countries including France & UK

7  feb 2013

French drugmaker Ipsen  and US partner Braintree Laboratories yesterday announced today that Eziclen/Izinova (BLI-800) has successfully completed its European decentralized registration procedure involving 16 countries, paving the way for a launch of the product before the end of 2013.

The product will be indicated in adults for bowel cleansing prior to any procedure requiring a clean bowel (eg, bowel visualization including bowel endoscopy and radiology or surgical procedure). Each European Union member states (France [reference member state], Belgium, Czech Republic, Estonia, Germany, Greece, Italy, Latvia, Lithuania, Luxemburg, the Netherlands, Poland, Portugal, Romania, Spain and UK) should now adopt a national decision within 30 days. In practice, the grant of the national marketing authorization may vary from one to several months, Ipsen noted.

Jean Fabre, senior vice president Intercontinental Operations and Franchise “Primary Care” at Ipsen, stated: “The completion of the decentralized procedure for Eziclen/Izinova (BLI-800) is an important step forward to national marketing authorizations in Europe. The availability of Eziclen/Izinova (BLI-800) will provide physicians and patients with a valuable agent for pre-colonoscopy colonic cleansing, particularly in the screening of colorectal cancer. This decision gives also perspectives for our plant in Dreux where Eziclen/Izinova will be manufactured”.

In 2009, Ipsen acquired the exclusive manufacturing, marketing and distribution rights of Braintree’s proprietary formulation BLI-800. The agreement covers countries within the EU, Commonwealth of Independent States, selected Asian countries (including China) and some North African countries. This product was approved by US Food and Drug Administrtion in 2010 and is marketed as Suprep Bowel Prep Kit.


1 Comment

  1. What i don’t realize is in truth how you are no longer really a lot more
    smartly-preferred than you might be now. You’re so intelligent.
    You recognize therefore significantly on the subject of this subject, made me for my part believe it from a lot of varied angles.
    Its like women and men are not interested unless it is one thing to do with Woman gaga!
    Your personal stuffs outstanding. At all times care for it up!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

DR ANTHONY CRASTO

Follow New Drug Approvals on WordPress.com

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,752 other followers
DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO Ph.D

DR ANTHONY MELVIN CRASTO, Born in Mumbai in 1964 and graduated from Mumbai University, Completed his Ph.D from ICT, 1991,Matunga, Mumbai, India, in Organic Chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues, Currently he is working with GLENMARK LIFE SCIENCES LTD, Research Centre as Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India. Total Industry exp 30 plus yrs, Prior to joining Glenmark, he has worked with major multinationals like Hoechst Marion Roussel, now Sanofi, Searle India Ltd, now RPG lifesciences, etc. He has worked with notable scientists like Dr K Nagarajan, Dr Ralph Stapel, Prof S Seshadri, Dr T.V. Radhakrishnan and Dr B. K. Kulkarni, etc, He did custom synthesis for major multinationals in his career like BASF, Novartis, Sanofi, etc., He has worked in Discovery, Natural products, Bulk drugs, Generics, Intermediates, Fine chemicals, Neutraceuticals, GMP, Scaleups, etc, he is now helping millions, has 9 million plus hits on Google on all Organic chemistry websites. His friends call him Open superstar worlddrugtracker. His New Drug Approvals, Green Chemistry International, All about drugs, Eurekamoments, Organic spectroscopy international, etc in organic chemistry are some most read blogs He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 30 PLUS year tenure till date June 2021, Around 35 plus products in his career. He has good knowledge of IPM, GMP, Regulatory aspects, he has several International patents published worldwide . He has good proficiency in Technology transfer, Spectroscopy, Stereochemistry, Synthesis, Polymorphism etc., He suffered a paralytic stroke/ Acute Transverse mylitis in Dec 2007 and is 90 %Paralysed, He is bound to a wheelchair, this seems to have injected feul in him to help chemists all around the world, he is more active than before and is pushing boundaries, He has 9 million plus hits on Google, 2.5 lakh plus connections on all networking sites, 90 Lakh plus views on dozen plus blogs, 233 countries, 7 continents, He makes himself available to all, contact him on +91 9323115463, email amcrasto@gmail.com, Twitter, @amcrasto , He lives and will die for his family, 90% paralysis cannot kill his soul., Notably he has 33 lakh plus views on New Drug Approvals Blog in 233 countries......https://newdrugapprovals.wordpress.com/ , He appreciates the help he gets from one and all, Friends, Family, Glenmark, Readers, Wellwishers, Doctors, Drug authorities, His Contacts, Physiotherapist, etc

Personal Links

View Full Profile →

TWITTER

  • RT @aasiri: #جائزة_نوبل في #الفيزياء لعام ٢٠٢٢ لثلاثة علماء 13 hours ago
  • RT @OPRD_ACS: Process chemists from @boehringerus report an efficient asymmetric synthesis of a chiral tetrahydropyran, a key intermediate… 1 day ago
  • RT @visitmaldives: Maldives holiday resort which is perfect for for families and EVERYTHING included. #WorldsLeadingDestination2021 #Maldi1 day ago
  • RT @weddingsutra: Bollywood stars @therichachadha and @alifazal9 wed in a beautiful, intimate ceremony in his home town Lucknow, planned by… 1 day ago
  • Teaching Some classroom pictures 📸 https://t.co/7drMwQCvMc 1 day ago
  • RT @aasiri: علاقة المتشكلات R و S مع بعضها البعض. الثلاثة اشكال الموضحة بالصورة لنفس المركب مع تشكلات مختلفة حول المركز الكيرالي. عند تع… 1 day ago
  • RT @aasiri: اعلان انشاء مجتمع "الكيمياء" الجميع مدعو للدخول إلى مجتمع "الكيمياء". هدف إنشاءه هو نشر محتوى راقي ومتخصص بالاتجاهات الحديثة… 1 day ago
  • RT @aasiri: حدد نوع التشكل R او S حول المركز الكيرالي للمركبات التالية #الكيمياء #معلومات_كيميائية #الكيمياء_في_حياتنا #الكيمياء_العضوية… 1 day ago
  • RT @csir_ncl: प्रेस विज्ञप्ति: सीएसआईआर- राष्‍ट्रीय रासायनिक प्रयोगशाला (एनसीएल) में राजभाषा हिन्‍दी पखवाड़ा समारोह का आयोजन @CSIR_IND @Ash1 day ago
  • RT @SciUp: Development of a Telescoped Alkylation/Reduction Reaction Sequence and an Asymmetric Hydrogenation to Enable the Kilogram Synthe… 1 day ago
  • RT @aasiri: الكيرالية Chirality الذرة الكيرالية هي الذرة التي تحتوي على اربع مجموعات مختلفة. هناك قواعد لتحديد كون المركب التشكل R او S.… 2 days ago
  • RT @csiriiim: @csiriiim celebrates the 81st #foundation day of @CSIR_IND. Prof. Amitabha Chattopadhyay, CSIR Bhatnagar Fellow was the chief… 2 days ago
  • RT @csiriict: सीएसआईआर-भारतीय रासायनिक प्रौद्योगिकी संस्थान (सीएसआईआर-आईआईसीटी), हैदराबाद में दिनांक 03 अक्टूबर, 2022 को हिंदी पखवाड़ा समाप… 2 days ago
  • Glenmark Pharmaceuticals Ltd up for five straight sessions mybs.in/2b1JA6t 2 days ago
  • RT @csir_ncl: 30 सितंबर 2022 को हिन्दी पखवाड़ा समारोह पुरस्कार वितरण एवं एनसीएल आलोक पत्रिका विमोचन कार्यक्रम का आयोजन किया गया, जिसमें मु… 2 days ago

bloglovin

Follow my blog with Bloglovin The title of your home page You could put your verification ID in a comment Or, in its own meta tag Or, as one of your keywords Your content is here. The verification ID will NOT be detected if you put it here.
%d bloggers like this: